NeoGenomics Inc (NEO) — Cash Flow Reinvestment Rate
NeoGenomics Inc (NEO) has a Cash Flow Reinvestment Rate of 0.41x as of June 2026, reinvesting $8.22 Million (capex $8.22 Million ) from operating cash flow of $19.96 Million. See NeoGenomics Inc (NEO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NeoGenomics Inc Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for NeoGenomics Inc across 11 annual periods. For the full cash flow conversion analysis, see NeoGenomics Inc (NEO) cash flow conversion.
Annual Cash Flow Reinvestment Rate for NeoGenomics Inc (2011–2025)
Year-by-year capital reinvestment analysis for NeoGenomics Inc. See NeoGenomics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.90x | $46.57 Million | $5.23 Million | $27.01 Million | ▲ +16.0% |
| 2024 | 7.68x | $53.92 Million | $7.02 Million | $41.06 Million | ▼ -90.8% |
| 2020 | 83.86x | $122.44 Million | $1.46 Million | $29.10 Million | ▲ +4841.7% |
| 2019 | 1.70x | $39.66 Million | $23.37 Million | $20.03 Million | ▼ -50.6% |
| 2018 | 3.44x | $154.00 Million | $44.79 Million | $14.31 Million | ▲ +126.5% |
| 2017 | 1.52x | $27.38 Million | $18.04 Million | $13.69 Million | ▲ +132.3% |
| 2016 | 0.65x | $14.04 Million | $21.48 Million | $7.54 Million | ▲ +88.6% |
| 2015 | 0.35x | $2.21 Million | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $3.77 Million | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.01 Million | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $897.00K | $69.00K | $897.00K | — |